Hills Bank & Trust’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $320K | Sell |
3,540
-4,472
| -56% | -$410K | 0.02% | 251 |
|
|
2025
Q4 | $720K | Sell |
8,012
-14,826
| -65% | -$1.41M | 0.04% | 180 |
|
|
2025
Q3 | $2.25M | Sell |
22,838
-591
| -3% | -$58.6K | 0.13% | 97 |
|
|
2025
Q2 | $2.14M | Sell |
23,429
-620
| -3% | -$60K | 0.13% | 97 |
|
|
2025
Q1 | $2.72M | Sell |
24,049
-321
| -1% | -$34.3K | 0.19% | 76 |
|
|
2024
Q4 | $2.57M | Sell |
24,370
-51
| -0.2% | -$5.47K | 0.19% | 80 |
|
|
2024
Q3 | $2.64M | Sell |
24,421
-539
| -2% | -$58.8K | 0.2% | 82 |
|
|
2024
Q2 | $2.71M | Sell |
24,960
-123
| -0.5% | -$14.5K | 0.22% | 76 |
|
|
2024
Q1 | $3.31M | Sell |
25,083
-335
| -1% | -$41.8K | 0.28% | 65 |
|
|
2023
Q4 | $3.09M | Sell |
25,418
-185
| -0.7% | -$20.6K | 0.3% | 64 |
|
|
2023
Q3 | $2.87M | Sell |
25,603
-8
| -0% | -$1.02K | 0.33% | 56 |
|
|
2023
Q2 | $3.73M | Buy |
25,611
+95
| +0.4% | +$12.9K | 0.48% | 43 |
|
|
2023
Q1 | $3.3M | Buy |
25,516
+142
| +0.6% | +$17.8K | 0.46% | 44 |
|
|
2022
Q4 | $3.23M | Sell |
25,374
-327
| -1% | -$37.9K | 0.48% | 43 |
|
|
2022
Q3 | $2.69M | Buy |
25,701
+300
| +1% | +$32.9K | 0.4% | 46 |
|
|
2022
Q2 | $2.67M | Sell |
25,401
-264
| -1% | -$31.3K | 0.43% | 48 |
|
|
2022
Q1 | $3.28M | Sell |
25,665
-392
| -2% | -$47.3K | 0.47% | 43 |
|
|
2021
Q4 | $3.21M | Buy |
26,057
+352
| +1% | +$46.1K | 0.44% | 47 |
|
|
2021
Q3 | $3.65M | Buy |
25,705
+331
| +1% | +$48.7K | 0.55% | 37 |
|
|
2021
Q2 | $3.96M | Sell |
25,374
-139
| -0.5% | -$22.5K | 0.6% | 35 |
|
|
2021
Q1 | $3.96M | Buy |
25,513
+92
| +0.4% | +$14.3K | 0.64% | 33 |
|
|
2020
Q4 | $3.8M | Sell |
25,421
-323
| -1% | -$45.6K | 0.66% | 31 |
|
|
2020
Q3 | $3.4M | Sell |
25,744
-1,051
| -4% | -$137K | 0.67% | 32 |
|
|
2020
Q2 | $3.1M | Buy |
26,795
+2,334
| +10% | +$269K | 0.66% | 34 |
|
|
2020
Q1 | $2.4M | Buy |
24,461
+2,202
| +10% | +$289K | 0.71% | 32 |
|
|
2019
Q4 | $3.23M | Sell |
22,259
-215
| -1% | -$29.7K | 0.76% | 28 |
|
|
2019
Q3 | $3M | Sell |
22,474
-694
| -3% | -$89.6K | 0.76% | 29 |
|
|
2019
Q2 | $2.65M | Sell |
23,168
-2
| -0% | -$234 | 0.69% | 33 |
|
|
2019
Q1 | $2.87M | Buy |
23,170
+1,001
| +5% | +$114K | 0.77% | 31 |
|
|
2018
Q4 | $2.23M | Sell |
22,169
-460
| -2% | -$51.7K | 0.69% | 35 |
|
|
2018
Q3 | $2.89M | Buy |
22,629
+138
| +0.6% | +$16.4K | 0.78% | 31 |
|
|
2018
Q2 | $2.43M | Buy |
22,491
+179
| +0.8% | +$19.5K | 0.7% | 36 |
|
|
2018
Q1 | $2.36M | Buy |
22,312
+394
| +2% | +$45.8K | 0.71% | 34 |
|
|
2017
Q4 | $2.57M | Sell |
21,918
-75
| -0.3% | -$8.48K | 0.75% | 31 |
|
|
2017
Q3 | $2.5M | Buy |
21,993
+10,391
| +90% | +$1.2M | 0.79% | 30 |
|
|
2017
Q2 | $1.45M | Buy |
11,602
+556
| +5% | +$65.9K | 0.47% | 48 |
|
|
2017
Q1 | $1.31M | Buy |
11,046
+788
| +8% | +$89.3K | 0.44% | 50 |
|
|
2016
Q4 | $1.03M | Buy |
10,258
+236
| +2% | +$25.3K | 0.36% | 61 |
|
|
2016
Q3 | $1.26M | Buy |
10,022
+2,683
| +37% | +$331K | 0.46% | 54 |
|
|
2016
Q2 | $858K | Buy |
7,339
+433
| +6% | +$49K | 0.32% | 66 |
|
|
2016
Q1 | $715K | Buy |
6,906
+4,073
| +144% | +$394K | 0.26% | 72 |
|
|
2015
Q4 | $282K | Buy |
+2,833
| New | +$277K | 0.11% | 95 |
|
Other funds holding ZBH
VCM
VPM
Hills Bank & Trust's ZBH Position: Q1 2026 in Review
Hills Bank & Trust reduced its Zimmer Biomet (ZBH) stake by 56% in Q1 2026, selling an estimated $410K and leaving 3,540 shares worth $320K. The position accounts for 0.02% of the portfolio, ranked #251.
Hills Bank & Trust first reported a position in ZBH in Q4 2015 and has held it in 42 quarters since. The position peaked at $3.96M in Q1 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Hills Bank & Trust held 3,540 shares of Zimmer Biomet worth $320K as of Q1 2026.
- Hills Bank & Trust sold 4,472 Zimmer Biomet shares in Q1 2026, an estimated $410K.
- Zimmer Biomet made up 0.02% of Hills Bank & Trust's portfolio in Q1 2026, its #251 holding.
- Hills Bank & Trust first reported a position in Zimmer Biomet in Q4 2015 and has held it in 42 quarters since.
- Hills Bank & Trust's Zimmer Biomet position peaked at $3.96M in Q1 2021.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Hills Bank & Trust's 13F filing for Q1 2026, filed 1 May 2026.